Mike, 33, from London was diagnosed with a brain tumour back in 2015. With a busy career, his diagnosis came as a real shock to him. It’s a cliché but, his life changed overnight.
He quickly started on a course of treatment. After having surgery to relieve pressure on his brain, he was informed that a biopsy would not be possible as the tumour was simply too close to his optic nerve. He was started on a course of chemotherapy and radiotherapy. Fortunately, this treatment put Mike into remission, until last year, when an MRI showed some tumour progression. Another course of chemotherapy was then commenced.
Through his treatment Mike has managed to continue to work and tried as much as possible to continue with his normal life. In October last year he turned to HSC for help, having cancer support via his employer’s scheme.
At the core of the HSC service is the provision of a dedicated care team. Mike’s team stepped into action, his case manager completed his personal needs based assessment and his dedicated HSC nurse specialist completed a comprehensive cancer care review. It was recommended that he took advantage of the second expert opinion which forms part of the HSC service. His case manager arranged this and provided a shortlist of suitable specialists.
“Having a second opinion has given me new treatment options and my specialist cancer nurse has provided important reassurance that no stone is being unturned in my future care.”
Once a specialist had been selected, the expert second opinion was arranged for Mike and his HSC specialist cancer nurse to attend. At the consultation Mike’s specialist nurse was by his side to ask questions and take notes. A thorough written summary allowed valuable time for reflection and ensured all questions were answered.
The second opinion was extremely valuable and recommended that Mike’s case was referred to a MDT (multidisciplinary clinical team). This clinical panel review suggested that the diagnosis did not match the client’s presentation, his overall health and disease progression. They recommended that if there was further disease progression after the next MRI scan a biopsy should be taken. This biopsy could highlight new options for a future treatment pathway.
After his expert review, Mike’s diagnosis has been re-evaluated and he now may have additional options for his treatment in the future.
Mike now is awaiting a further MRI scan to check for any disease progression. In the meantime, he is enjoying life and manging his symptoms well.